In a nuclear or radiological incident, first responders must quickly measure the radiation exposure of a large number of individuals, since treatment options are radiation dose-dependent and time-sensitive. SRI is developing a biodosimeter to meet this critical challenge.
Innovative Science Overcomes Formulation Challenges
A new oral version of a known chelating agent can defend against mass radiation exposure in a terrorist attack.
Partnering to Advance Therapy for Radiation Exposure
SRI is developing a method to enable rapid, large-scale response to a bioterrorism threat or an infectious disease epidemic.